Clinical Trial Update: Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating crizotinib with combination chemotherapy in younger patients with relapsed or refractory solid tumors or anaplastic large cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Childhood Solid Tumor
• Neuroblastoma

Drugs mentioned

• Crizotinib (crizotinib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Solid Neoplasm, Recurrent Childhood Anaplastic Large Cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2024-01-05